Peptilogics
Peptilogics is a clinical-stage biotechnology company revolutionizing peptide therapeutics discovery by combining peptide biology with machine learning and high-performance computing. Their AI-driven platform enables in silico predictive design of novel peptides optimized for binding, selectivity, safety, and drug-like properties, targeting serious and life-threatening diseases with high unmet medical needs. Founded in 2013, Peptilogics advances a pipeline including PLG0206, a broad-spectrum anti-infective peptide therapeutic. The company integrates peptide R&D, proprietary AI technologies, and computational power to unlock new chemical space and accelerate drug discovery at unprecedented scale and pace, positioning itself as a leader in peptide drug design innovation.
Peptilogics
Peptilogics is a clinical-stage biotechnology company revolutionizing peptide therapeutics discovery by combining peptide biology with machine learning and high-performance computing. Their AI-driven platform enables in silico predictive design of novel peptides optimized for binding, selectivity, safety, and drug-like properties, targeting serious and life-threatening diseases with high unmet medical needs. Founded in 2013, Peptilogics advances a pipeline including PLG0206, a broad-spectrum anti-infective peptide therapeutic. The company integrates peptide R&D, proprietary AI technologies, and computational power to unlock new chemical space and accelerate drug discovery at unprecedented scale and pace, positioning itself as a leader in peptide drug design innovation.
